Using kisspeptin antagonists as contraceptives in female patients or therapeutically in sex-steroid-dependent pathologies, such as breast cancer, endometriosis, uterine fibroid, or prostate cancer, represents an essential subject to be investigated [37]. Here, KISS1 is linked to breast carcinoma.